You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for SM TUSSIN MUCUS-CONG


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SM TUSSIN MUCUS-CONG

Average Pharmacy Cost for SM TUSSIN MUCUS-CONG

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SM TUSSIN MUCUS-CONG 200 MG/10 49348-0135-34 0.02316 ML 2025-01-22
SM TUSSIN MUCUS-CONG 200 MG/10 49348-0135-34 0.02310 ML 2024-12-18
SM TUSSIN MUCUS-CONG 200 MG/10 49348-0135-34 0.02326 ML 2024-11-20
SM TUSSIN MUCUS-CONG 200 MG/10 49348-0135-34 0.02321 ML 2024-10-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for SM Tussin Mucus-Congestion (Guaifenesin)

Introduction to Guaifenesin

Guaifenesin, the active ingredient in SM Tussin Mucus-Congestion, is an expectorant commonly used to treat cough and chest congestion. It works by thinning mucus in the air passages, making it easier to cough up. Here’s a comprehensive analysis of the market and price projections for this medication.

Market Size and Growth

The global guaifenesin market is expected to experience significant growth driven by several factors. The market size for expectorant drugs, which includes guaifenesin, is estimated to reach USD 120 million by 2029, growing at a CAGR of 4.5% from 2024 to 2029[4].

Segment Analysis

By Product

Guaifenesin is available in various forms, including tablets, dissolving granules, syrup, and extended-release tablets. The cough treatment drug segment, which includes guaifenesin, is the fastest-growing segment, expected to grow with a CAGR of around 3.7% during the forecast period[1].

By Application

The primary application of guaifenesin is in cough treatment drugs and chest congestion medications. Its use in these areas is boosting the growth in the market, particularly in hospitals, clinics, and other healthcare settings[1].

By End-Use Industry

The demand for guaifenesin is increasing in multispecialty hospitals and clinics. The growth in the pharmaceutical sector and advancements in drug delivery and processing are driving this demand[1].

By Geography

The market is geographically segmented into North America, Europe, Asia-Pacific, South America, the Middle East, and Africa. The Asia-Pacific region, particularly India, is expected to see significant growth due to the expansion of the pharmaceutical sector and hospital infrastructure[1].

Impact of COVID-19

The COVID-19 pandemic had a significant impact on the global guaifenesin market. Initially, the pandemic led to disruptions in production and supply chains, affecting the availability of medications. However, the increased demand for cough and cold medications during the recovery phase created growth opportunities for guaifenesin. Medicaid spending in the U.S. increased by 9.2% in 2020, and hospital spending saw a 6.4% increase, indicating a surge in healthcare activities[1].

Price Projections

Current Pricing

The cost for Tussin Mucus + Chest Congestion (guaifenesin) oral liquid is around $10 for a supply of 118 milliliters, depending on the pharmacy. Generic versions are also available, priced from $10.67 for 250 milliliters[2].

Future Pricing Trends

Given the growing demand and expanding market size, prices may remain relatively stable or see a slight increase. However, competition from generic versions and other expectorants could influence pricing. The launch of new drugs, such as the FDA-approved Mucinex DM Maximum Strength (guaifenesin and dextromethorphan hydrobromide extended-release tablets), may also impact pricing dynamics[5].

Market Drivers

  • Increasing Respiratory Complications: Rising cases of respiratory complications, cough, and chest congestion are driving the demand for guaifenesin[1].
  • Advancements in Pharmaceutical Sector: Innovations in drug delivery and processing, along with the expansion of hospital infrastructure, are boosting the market[1].
  • Growing Healthcare Spending: Increased spending in the healthcare sector, particularly in regions like India, is expected to drive the market growth[1].

Market Challenges

  • Availability of Substitutes: The presence of substitute medications can pose a challenge to the guaifenesin market[1].
  • Potential Side Effects: Concerns over side effects and stringent regulations against cough suppressants may affect market growth[5].

Revenue Forecasting Techniques

For new pharmaceutical drugs like guaifenesin, revenue forecasting involves several approaches:

  • Bottom-Up Market Analysis: This includes estimating the potential market size, addressing the target population, and analyzing incidence and prevalence of the disease or condition[3].
  • Analyst Insights and Research Reports: Cross-checking market estimations with external reports and similar product revenues helps in refining the forecasts[3].
  • Segmentation Analysis: Identifying different customer segments, such as severely, moderately, and mildly affected patients, helps in refining penetration and share forecasts[3].

Key Takeaways

  • The global guaifenesin market is expected to grow significantly, driven by increasing respiratory complications and advancements in the pharmaceutical sector.
  • The cough treatment drug segment is the fastest-growing segment, with a CAGR of around 3.7% during the forecast period.
  • The Asia-Pacific region, particularly India, is expected to see substantial growth due to expanding healthcare infrastructure and increased healthcare spending.
  • Pricing trends may remain stable or see a slight increase, influenced by competition and new drug launches.

FAQs

Q: What is the primary use of guaifenesin in medications? A: Guaifenesin is primarily used as an expectorant to treat cough and chest congestion by thinning mucus in the air passages.

Q: How has the COVID-19 pandemic impacted the guaifenesin market? A: The pandemic initially disrupted production and supply chains but later created growth opportunities due to increased demand for cough and cold medications.

Q: What are the key drivers of the guaifenesin market? A: Key drivers include increasing respiratory complications, advancements in the pharmaceutical sector, and growing healthcare spending.

Q: What are the challenges faced by the guaifenesin market? A: Challenges include the availability of substitute medications and potential side effects, along with stringent regulations against cough suppressants.

Q: How is the pricing of guaifenesin expected to trend in the future? A: Pricing is expected to remain relatively stable or see a slight increase, influenced by competition from generic versions and new drug launches.

Cited Sources

  1. IndustryARC, "Guaifenesin Market Size Report, 2022-2027"
  2. Drugs.com, "Tussin Mucus + Chest Congestion Prices, Coupons, Copay Cards & Patient Assistance"
  3. iHealthcareAnalyst, "Revenue Forecasting Techniques for New Pharmaceutical Drugs"
  4. Mordor Intelligence, "Expectorant Drugs Market Size & Share Analysis"
  5. Allied Market Research, "Guaifenesin Market Size, Trends | Industry Report 2021 - 2030"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.